# Investigating the Neuropsychological Effects of 5-HT2a Antagonism

> **NCT07022366** · NA · RECRUITING · sponsor: **University of Oxford** · enrollment: 80 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Pimavanserin 10mg
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07022366
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-10
- **Primary completion:** 2026-06
- **Final completion:** 2026-09
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07022366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07022366, "Investigating the Neuropsychological Effects of 5-HT2a Antagonism". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07022366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*